Analysis for KraneShares CSI China Internet ETF
Analysis summary
KraneShares CSI China Internet ETF (KWEB) currently has a total score of 17 points, placing it in the very weak range. The score is made up of Performance (15), Stability (20) and Trend (18). All three sub-scores are currently below average.
Performance scores 15 points (very weak). Least weak metric: 1Y return at -4.9 %. Main drag: 5Y return at -66.6 %. This points to a sharper upswing more recently.
Stability scores 20 points (weak). Least weak metric: max drawdown (1Y) at -27.2 %. Main drag: Sortino ratio (90d) at -2.01. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 18 points (very weak). Trend signals are mostly negative right now. Least weak metric: relative strength (12M) at 2.8 %. Main drag: trend strength at -0.90.
Overall, the picture is very weak: none of the three dimensions shows a clear strength. On a metric level, max drawdown (1Y) stands out, while trend strength is the main weak spot.
(Historical evaluation, not investment advice.)
Metrics
Stability
FAQ
- What investor type does KraneShares CSI China Internet ETF fit best in FoxScore?
- KraneShares CSI China Internet ETF looks fairly balanced in FoxScore: the sub-scores are close to each other. This often fits a diversified approach — then check the metrics (e.g., drawdowns/volatility) to see if they match your risk tolerance.
- How meaningful is the available history for KraneShares CSI China Internet ETF?
- KraneShares CSI China Internet ETF currently has about 12.5 years of price history since it started trading. That’s a solid base to interpret returns, drawdowns and trend behavior since launch — earlier market crises happened before the asset existed and are therefore not part of its history.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.